A phase I trial to evaluate ZD1839 [gefitinib] (Iressa[Tm]) and concurrent chemo-radiation in patients with locally advanced non small cell lung cancer [NSCLC]
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2007
At a glance
- Drugs Carboplatin; Gefitinib; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 18 Dec 2007 Status changed from in progress to completed.
- 13 Jan 2006 New trial record.